We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$36.4B
AUM Growth
+$3.53B
Cap. Flow
+$1.12B
Cap. Flow %
3.08%
Top 10 Hldgs %
20.83%
Holding
3,908
New
299
Increased
2,042
Reduced
1,302
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 12.56%
2 Financials 4.99%
3 Consumer Discretionary 3.69%
4 Communication Services 3.04%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QSI icon
3651
Quantum-Si Incorporated
QSI
$182M
$55K ﹤0.01%
38,867
AKBA icon
3652
Akebia Therapeutics
AKBA
$248M
$54K ﹤0.01%
+19,799
New +$65.9K
WKSP icon
3653
Worksport
WKSP
$10.3M
$54K ﹤0.01%
+15,500
New +$53.7K
CAN
3654
Canaan Creative
CAN
$154M
$53K ﹤0.01%
+59,551
New +$45.2K
CHMI
3655
Cherry Hill Mortgage Investment Corp
CHMI
$107M
$53K ﹤0.01%
22,352
+1,331
+6% +$3.69K
SLN
3656
Silence Therapeutics
SLN
$641M
$53K ﹤0.01%
10,194
ALIT icon
3657
Alight
ALIT
$377M
$50K ﹤0.01%
+774
New +$68.4K
AREC icon
3658
American Resources Corp
AREC
$300M
$50K ﹤0.01%
+18,664
New +$31.9K
SRFM icon
3659
Surf Air Mobility
SRFM
$98.2M
$50K ﹤0.01%
+11,550
New +$54.1K
BFLY icon
3660
Butterfly Network
BFLY
$2.52B
$49K ﹤0.01%
25,355
+5,189
+26% +$8.82K
LWLG icon
3661
Lightwave Logic
LWLG
$1.23B
$48K ﹤0.01%
12,961
ALT icon
3662
Altimmune
ALT
$570M
$47K ﹤0.01%
12,532
-6,136
-33% -$23.7K
NAT icon
3663
Nordic American Tanker
NAT
$1.36B
$46K ﹤0.01%
14,797
-1,522
-9% -$4.49K
CIF
3664
DELISTED
MFS Intermediate High Income Fund
CIF
$44K ﹤0.01%
+24,964
New +$43.8K
INMB icon
3665
INmune Bio
INMB
$56.6M
$44K ﹤0.01%
21,375
-11,200
-34% -$25.6K
HUMA icon
3666
Humacyte
HUMA
$179M
$41K ﹤0.01%
23,729
-5,067
-18% -$9.93K
BLNK icon
3667
Blink Charging
BLNK
$85.6M
$39K ﹤0.01%
23,752
-109
-0.5% -$121
KOPN icon
3668
Kopin
KOPN
$930M
$36K ﹤0.01%
14,980
-1,250
-8% -$2.55K
HOVR icon
3669
New Horizon Aircraft
HOVR
$133M
$35K ﹤0.01%
+13,900
New +$24.2K
ONCY
3670
Oncolytics Biotech
ONCY
$98.3M
$35K ﹤0.01%
24,771
+13,500
+120% +$15.1K
HRTX icon
3671
Heron Therapeutics
HRTX
$64.7M
$34K ﹤0.01%
26,622
-1,345
-5% -$2.13K
ANNX icon
3672
Annexon
ANNX
$873M
$33K ﹤0.01%
10,700
PLG
3673
Platinum Group Metals
PLG
$196M
$33K ﹤0.01%
12,627
+1,000
+9% +$1.71K
AGL icon
3674
Agilon Health
AGL
$1.45B
$32K ﹤0.01%
1,255
-3
-0.2% -$113
GEVO icon
3675
Gevo
GEVO
$391M
$32K ﹤0.01%
16,353
+1
+0% +$2

Similar funds

Cambridge Investment Research Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Cambridge Investment Research Advisors held 3,908 positions worth $36.4B, up 11% from $32.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $1.12B of net new capital in Q3 2025, opening 299 new positions and adding to 2,042 existing holdings. Its largest new stake was Scharf ETF: 195,274 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $27.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2025 buy was Scharf ETF: 195,274 shares worth $11M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q3 2025, an estimated $67.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $27.2M.
  • Cambridge Investment Research Advisors fully exited iShares Large Cap Deep Quarterly Laddered ETF in Q3 2025, selling an estimated $8.43M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $36.4B portfolio in Q3 2025.
  • Cambridge Investment Research Advisors opened 299 new positions and closed 193 in Q3 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $36.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.